Atlas Trials

Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

Clinical trial NCT02232191 · RECRUITING

Trial details

NCT number
NCT02232191
Sponsor
University of California, Davis
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Asplenia
Start date
2014-12-01
Primary completion
2027-07-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.